|
| Bacteria's | Skin Manifestations | Treatment |
|
| Mycobacterium tuberculosis | Mycobacterium tuberculosis infection is rare after transplantation. | Directly observed Therapy with following drugs: pyrazinamide, rifampin, ethambutol, and isoniazid. |
|
| Nocardia | Responsible for subcutaneous abscesses and nocardiosis. | For lymphocutaneous type combination therapy with imipenem and cefotaxime, amikacin and TMP-SMX. However, superficial skin infections often resolve with empiric antibiotics. |
|
| Staphylococcus aureus | Responsible for surgical site infection, pyoderma, staphylococcal scalded skin syndrome, and toxic shock syndrome. | Intravenous flucloxacillin |
|
| E. coli | Responsible for necrotizing fasciitis. | Surgical debridement and earlier treatment with broad-spectrum antibiotics in addition to intravenous vancomycin or intravenous daptomycin. |
|
| Streptococcus | Responsible for impetigo contagiosa, cellulitis, and ecthyma. | Topical mupirocin antibiotic ointment or retapamulin ointment for 5-7 days. |
|
| Bartonella | Responsible for bacillary angiomatosis. | Erythromycin appears to be the antibiotic of choice and is given until lesions resolve, usually within 3-4 weeks of starting therapy. Other antibiotics used include doxycycline, TMP-SMX, tetracycline, and rifampicin. |
|
| Pseudomonas aeruginosa | Responsible for ecthyma gangrenosum and necrotizing fasciitis. | Surgical debridement and earlier treatment with broad-spectrum antibiotics in addition to intravenous vancomycin or intravenous daptomycin. |
|
| Nontuberculous mycobacteria (Mycobacterium marinum, M. haemophilum, M. fortuitum, M. chelonae, M. abscessus, and M. ulcerans, or M. immunogenum) | Responsible for macular erythema, nonhealing ulcers, erythematous nodules, and papules. | The treatment regimens vary greatly depending on the species and treatment may be required for at least 12 months. |
|
